Daniel Karp - 09 Sep 2024 Form 3 Insider Report for Organon & Co. (OGN)

Role
Executive VP, Corp. Dev.
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Daniel Karp
Issuer symbol
OGN
Transactions as of
09 Sep 2024
Net transactions value
$0
Form type
3
Filing time
17 Sep 2024, 16:04:28 UTC
Next filing
02 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding OGN Common Stock 19,362 09 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OGN Restricted Stock Units 09 Sep 2024 Common Stock 4,294 $0.000000 Direct F1, F2
holding OGN Restricted Stock Units 09 Sep 2024 Common Stock 4,861 $0.000000 Direct F1, F2
holding OGN Restricted Stock Units 09 Sep 2024 Common Stock 22,676 $0.000000 Direct F2, F3
holding OGN Restricted Stock Units 09 Sep 2024 Common Stock 42,553 $0.000000 Direct F2, F4
holding OGN Stock Option (right to buy) 09 Sep 2024 Common Stock 28,996 $36.11 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units vest and are distributed as shares of Organon & Co. common stock on March 31, 2025.
F2 Each restricted stock unit represents a contingent right to receive one share of Organon & Co. common stock.
F3 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in equal installments on each of March 31, 2025 and March 31, 2026.
F4 These restricted stock units vest and are distributed as shares of Organon & Co. common stock in equal installments on each of March 29, 2025, March 29, 2026 and March 29, 2027.
F5 28,996 shares underlying the option are fully vested and exercisable.

Remarks:

Exhibit 24 - Power of Attorney